FRANK RUSSO: Open Payments
NPI 1437305786 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,689 in 117 payments from 13 companies in 2025. Trend: 2023 $2,013 · 2024 $1,803 · 2025 $2,689
Food & beverage: $2,578Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $465 |
| Teva Pharmaceuticals USA, Inc. | 17 | $419 |
| Otsuka America Pharmaceutical, Inc. | 11 | $291 |
| Neurocrine BioSciences, Inc. | 13 | $270 |
| Alkermes, Inc. | 12 | $252 |
| E.R. Squibb & Sons, L.L.C. | 6 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $228 |
| Axsome Therapeutics, Inc. | 9 | $219 |
| Janssen Pharmaceuticals, Inc | 5 | $102 |
| Vanda Pharmaceuticals Inc. | 5 | $98 |
Products named: VRAYLAR, INGREZZA, REXULTI, ARISTADA, COBENFY, CAPLYTA, Auvelity, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
